Drug Shortage Report for MESNA FOR INJECTION

Last updated on 2024-01-09 History
Report ID 201038
Drug Identification Number 02244931
Brand name MESNA FOR INJECTION
Common or Proper name MESNA FOR INJECTION
Company Name FRESENIUS KABI CANADA LTD
Market Status MARKETED
Active Ingredient(s) MESNA
Strength(s) 100MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 10mL
ATC code V03AF
ATC description ALL OTHER THERAPEUTIC PRODUCTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2023-06-30
Estimated end date Unknown
Actual end date
Shortage status Actual shortage
Updated date 2024-01-09
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 165 GALAXY BLVD, SUITE 100
TORONTO, ONTARIO
CANADA M9W 0C8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v10 2024-01-09 French Compare
v9 2024-01-09 English Compare
v8 2023-11-29 French Compare
v7 2023-11-29 English Compare
v6 2023-11-29 French Compare
v5 2023-11-29 English Compare
v4 2023-09-18 French Compare
v3 2023-09-18 English Compare
v2 2023-08-03 French Compare
v1 2023-08-03 English Compare

Showing 1 to 10 of 10